This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kozaki, S
Right arrow Articles by Sakaguchi, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kozaki, S
Right arrow Articles by Sakaguchi, G

 Previous Article  |  Next Article 

Infect Immun. 1977 December; 18(3): 761-766

Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.

S Kozaki, S Miyazaki and G Sakaguchi

ABSTRACT

Two fragments with molecular weights of 111,000 (fragment I) and 59,000 (fragment II) were separated from each other by gel filtration of dithiothreitol and urea-treated, trypsinized derivative toxin (molecular weight, 170,000) of the proteolytic Okra strain of Clostridium botulinum type B on a column of Sephadex G-200 (superfine) with a buffer containing dithiothreitol and urea. Upon removal of dithiothreitol and urea by dialysis, the two fragments reassembled to reconstruct the derivative toxin molecule. Both fragments were immunogenic, and both anti-fragments neutralized type B toxin. The neutralizing activities of both anti-fragment I and anti-fragment II were, however, lower than that of the anti-derivative toxin, suggesting that the molecular integrity of derivative toxin is essential for sufficient production of the neutralizing antibody. The immunological difference found between type B toxin from a proteolytic strain and that from a nonproteolytic strain was ascribed to the antigenic difference of fragment I.


Infect Immun. 1977 December; 18(3): 761-766




This article has been cited by other articles:

  • Kozaki, S., Kamata, Y., Nishiki, T.-i., Kakinuma, H., Maruyama, H., Takahashi, H., Karasawa, T., Yamakawa, K., Nakamura, S. (1998). Characterization of Clostridium botulinum Type B Neurotoxin Associated with Infant Botulism in Japan. Infect. Immun. 66: 4811-4816 [Abstract] [Full Text]